News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Tribe WOD Founders Sue Factory 14 and Razor Group, Alleging Fraud and Breach of Contract

Tribe WOD

The founders of Tribe WOD, a prominent cross-training and fitness equipment manufacturer, have filed a lawsuit against brand aggregators Factory 14 and Razor Group, citing deceit, fraud, breach of contract, unfair and deceptive trade practices, and unjust enrichment, among other offenses. The lawsuit, filed in Massachusetts Superior Court, alleges that the defendants, Factory 14 and Razor Group, failed to fulfill promises made during the acquisition of Tribe WOD. Alleged breaches of the agreement include failure to make earn-out payments as well as failing to provide access to business records – all outlined in the acquisition contract. Originating from a humble Massachusetts garage, Tribe WOD founders Alexandre Vitet and Jared Bane built their company into a $2.5 million enterprise before selling it to Factory 14, which later resold it to Razor Group. Despite promises of global expansion, enhanced marketing, access to industry experts, and potential earn-out payments, the plaintiffs argue that the defendants neglected their commitments, substantially harming the company and disregarding U.S. laws and business practices. Tribe WOD, which launched in 2019, swiftly grew to over $2.5 million in sales in just a few months, establishing strong sales channels via Amazon, Shopify, and various online platforms. This success attracted several potential buyers, with Factory 14 standing out due to its promise of multiple payments tied to Tribe WOD's annual earnings through earn-outs. The lawsuit contends that shortly after the acquisition, Factory 14 sold the assets of Tribe WOD to Razor Group, bypassing an anti-assignment provision in the original agreement. It is alleged that Factory 14 knowingly withheld information regarding this potential transaction from the plaintiffs. According to the lawsuit, Vitet and Bane had doubled revenue year-over-year and had expected to, at a minimum, match that. The lawsuit states that based on the promises made during the courtship and due diligence phase, there were immediate red flags after signing the acquisition agreement, and the situation quickly spiraled downward. Moreover, the complaint asserts that both Factory 14 and Razor Group systematically dismantled Tribe WOD, dismissing in-house creative content specialists and neglecting basic operational necessities. According to the lawsuit, Factory 14 and Razor Group failed to comply with federal and state tax, wage, and import laws and otherwise mismanaged the business financially. The lawsuit also states that the defendants had no U.S. bank account or credit card and were unable to obtain either and thus were unable to pay any of the company’s bills. The lawsuit alleges that the failure to pay basic bills led to lost revenue and the ability to serve existing customers or expand to new markets. The plaintiffs claim that their consulting agreements were prematurely terminated and allege that income from Tribe WOD was siphoned off to other businesses. The lawsuit alleges that Factory 14 and Razor Group essentially turned a thriving brand built by the founders with a rabid customer following into an Amazon seller with no identity, and loaded with unnecessary fees. The lawsuit seeks compensatory and multiple damages and injunctive relief, compelling the defendants to provide accurate and complete financial data. Interestingly, Razor Group faces a similar lawsuit in Texas, as it is being sued by the founders of Kettlebell Kings in a case with similar allegations. On its website, Razor Group states that it is trusted by leading investors Blackrock, Victory Park Capital, and Fortress among others. The Tribe WOD lawsuit was filed in Massachusetts Superior Court by Garage Sweat, LLC f/k/a Tribe Wod, LLC, Jared Bane, and Alexandre Vitet against Factory 14 UK Acquisition IV, Ltd., Razor Group GMBH, and Razor Group USA, LLC. This case has been accepted into and will be litigated in the Business Litigation Session, a business-focused sub-department of the Massachusetts Superior Court sited in Boston, Suffolk County, Massachusetts. The lawsuit can be downloaded here and at LawsuitPressRelease.com. -end- Source: Garage Sweat, LLC f/k/a Tribe WOD, LLC Contact Details LawsuitPressRelease.com John P. David +1 888-859-6637 john@LawsuitPressRelease.com

June 26, 2023 11:01 AM Eastern Daylight Time

Article thumbnail News Release

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows

STORM Partners

FinancialNewsMedia.com News Commentary - Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one of the factors driving the need for the drugs used in the treatment. The increase in the geriatric population is one factor driving the pancreatic cancer treatment market growth. The incidence is significantly higher in the geriatric population above 65 years of age compared to other types of cancers. The increase in the number of patients suffering from the condition has increased the demand for the drugs used in treatment. A report from Fortune Business Insights said that this factor will be driving the growth for the next several years. The report projected that the global pancreatic cancer treatment market size was valued at USD 2.48 billion in 2022 and will grow to USD 6.85 billion by 2029, exhibiting a CAGR of 15.7% during the forecast period. The report continued: “Companies engaged in manufacturing cancer drugs have increased their focus on R&D activities to develop new drugs for pancreatic cancer treatment. Additionally, the companies operating in the market have received approval from several regulatory bodies, such as the U.S. Food and Drug Administration (FDA), the Medicines and Healthcare Products Regulatory Agency (MHRA) (U.K.), among others, thereby propelling the growth of the market. Moreover, new testing technologies are being adopted by hospitals and diagnostic centers to diagnose cancer. The increase in the diagnosis rates is driving the demand for drugs, thereby providing opportunities for the players.” Active biotech and pharma companies in the markets this week include Oncolytics Biotech ® Inc. (ONCY – ONC.TSX), Sotera Health Company (NASDAQ: SHC), Centessa Pharmaceuticals plc (NASDAQ: CNTA), Bristol Myers Squibb (NYSE: BMY), Gilead Company (NASDAQ: GILD). Fortune Business Insights continued: “Shifting the focus of key players in extensive R&D activities to develop new drugs and an increase in funding for cancer research led to the development of new drugs for treatment. Additionally, several pharmaceutical companies are involved in clinical trials to develop new drugs and explore the potential of the molecule to treat the disease. It concluded: “Thus, with the increased funding for R&D activities, companies are focused on developing new drugs, thereby contributing to the overall rise in demand for drugs for pancreatic type of cancer treatment through 2029.” Oncolytics Biotech ® Inc. (ONCY - ONC) BREAKING NEWS: Oncolytics Biotech’s® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial – Adaptive clinical trial designed to accelerate registration pathways for pancreatic cancer therapies and expected to reduce cost of a Phase 3 study for pelareorep by ~50% compared to a traditional trial If successful, new clinical study expected to support approval of pelareorep in combination with a checkpoint inhibitor, gemcitabine, and nab-paclitaxel in first-line metastatic pancreatic cancer Data presented at SITC 2022 showed a near tripling of overall response rate for pelareorep + gemcitabine + nab-paclitaxel + a PD-L1 inhibitor compared to historical control trials Oncolytics Biotech ® (trading on the NASDAQ under the Symbol ONCY and the TSX exchange under ONC) today announced pelareorep has been selected for inclusion as a new investigational treatment in Precision PromiseSM, an innovative adaptive Phase 3 clinical trial. The Precision Promise study is designed to evaluate pelareorep in combination with a checkpoint inhibitor and the chemotherapeutic agents gemcitabine and nab-paclitaxel. If successful, the clinical study is expected to support approval of the studied combination as a treatment for first-line metastatic pancreatic ductal adenocarcinoma (PDAC). Precision Promise has a primary endpoint of overall survival and can include multiple investigational treatments as well as control arms evaluating: (1) gemcitabine plus nab-paclitaxel or (2) mFOLFIRINOX. Each investigational therapy is subject to pre-specified interim analyses prior to proceeding to the registrational portion of the trial. This design, which was developed with guidance from the U.S. Food and Drug Administration, minimizes the number of participants needed to generate licensure-enabling data, thereby accelerating late-stage development by up to two years and reducing costs compared to non-platform trials. “We are delighted at being selected by the Precision Promise panel of experts,” said Dr. Matt Coffey, President, and Chief Executive Officer of Oncolytics Biotech. “Our next step is to engage with stakeholders to finalize the protocol for Precision Promise’s pelareorep-containing investigational treatment so that we can enter into this study. We are thrilled to have the opportunity to leverage Precision Promise, which we expect will allow us to reduce the time and costs needed to reach a potential approval.” Julie Fleshman, JD, MBA, President and CEO of PanCAN commented, “With a five-year survival rate of 12%, pancreatic cancer patients cannot afford to wait for new treatment options. This urgent unmet need was the driving inspiration behind the Precision Promise platform trial, which was designed specifically to identify, accelerate, and de-risk the development of promising pancreatic cancer treatments. We are thrilled to be bringing pelareorep into Precision Promise as a new investigational therapy to study against the current standard of care.” Dr. Thomas Heineman, Chief Medical Officer of Oncolytics Biotech, commented, “Prior trials in pancreatic cancer show pelareorep-based combinations outperforming historical controls on key metrics such as one and two-year survival and objective response rate. In addition, mechanistic data from these studies highlight how pelareorep’s immunologic mechanism of action allows it to synergize with chemotherapy and checkpoint inhibition in this indication. I look forward to working with the Precision Promise team of investigators to seek to confirm the therapeutic value of pelareorep in a randomized setting so that we can potentially provide pancreatic cancer patients with a new treatment option.” CONTINUED …Read this full press release and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/ Other recent breast cancer developments in the biotech industry of note include: Sotera Health Company (NASDAQ: SHC) recently announced that the opt-in process for the January 2023 settlements of ethylene oxide claims against Sterigenics in the Circuit Court of Cook County, Illinois is complete and Sterigenics has elected to proceed with the settlements. 879 of the 882 claimants eligible to participate in the settlement program have opted in. The settling claimants and Sterigenics will now request that the Circuit Court enter an order confirming that these are good-faith settlements under the Illinois Contribution Among Joint Tortfeasors Act. The settlement funds will be released from escrow for disbursement to the settling claimants ten days after the Court enters the anticipated good-faith determination and their claims against Sterigenics will subsequently be dismissed with prejudice. The lawsuits of the three claimants who opted out of the settlement will proceed to pretrial discovery pursuant to a schedule to be set by the Circuit Court. Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SerpinPC, an investigational novel inhibitor of activated protein C (APC) being developed for the treatment of hemophilia B, with or without inhibitors. "We are pleased with the FDA’s decision to grant Fast Track designation for SerpinPC as we continue to advance the PRESent registrational studies for SerpinPC in hemophilia B,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. “This designation is important recognition of SerpinPC’s novel mechanism of action and underscores the critical need for new treatment options for persons with hemophilia B. We believe SerpinPC has the potential to be a first-in-class subcutaneously administered therapy with a differentiated safety profile for persons with hemophilia B, subject to review and approval.” Bristol Myers Squibb (NYSE: BMY) announced the first disclosure of primary analysis results from two pivotal studies, TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi (lisocabtagene maraleucel; liso-cel) in patients with relapsed or refractory follicular lymphoma (FL) and the relapsed or refractory mantle cell lymphoma (MCL) cohort of TRANSCEND NHL 001, an open-label, multicenter, Phase 1, single-arm, seamless-design study evaluating Breyanzi. These data were presented in late-breaking oral presentations at the 2023 International Conference on Malignant Lymphoma (ICML) on Saturday, June 17. "With Breyanzi, we’re dedicated to delivering a CAR T cell therapy with a differentiated profile to transform outcomes for some of the most difficult-to-treat lymphomas," said Anne Kerber, senior vice president, head of Cell Therapy Development, Bristol Myers Squibb. "Based on results from TRANSCEND FL and TRANSCEND NHL 001, Breyanzi continues to demonstrate the ability to elicit significant deep and durable responses alongside a manageable safety profile, potentially addressing areas of high unmet need and reinforcing our commitment to advancing innovative solutions for the broadest array of hematologic malignancies of any CD19-directed CAR T cell therapy." Kite Pharma, Inc., a Gilead Company (NASDAQ: GILD) announced that the Marketing Authorization in Japan for Yescarta® (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been transferred from Daiichi Sankyo Co., Ltd. to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences, Inc. This follows the announcement made by Daiichi Sankyo and Kite Pharma, Inc. in December 2022 about changes to their initial 2017 partnership whereby Daiichi Sankyo obtained the Marketing Authorization for Yescarta®. With this completion of the Marketing Authorization transfer, the sales and promotion activities of Yescarta® in Japan now will be managed by the Kite Cell Therapy Business Unit of Gilead Sciences K.K. DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech ® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements. SOURCE Financialnewsmedia.com Contact Details Financial News Media Media Contact +1 561-325-8757 editor@financialnewsmedia.com

June 23, 2023 01:09 PM Eastern Daylight Time

Article thumbnail News Release

Royal Ascot Day 4: Free Bets and Betting Offers

Acroud Media

Day four of the Royal Ascot 2023 is bound to be just as thrilling as the previous three days; just like the other days, day four will have seven races. One stand-out race on day four is the Group 1 Commonwealth Cup, which is only is only six furlongs long. If betting on day four interests you, why not check out some of the betting offers below? Best Betting Sites Bet365: Bet 10 Get 30 Bet365 has become one of the giants in the sports betting world, and it's not surprising given its huge range of games, promotions and sports betting markets. Users can find all of the popular sports betting options they could possibly want, including football, tennis and horse racing. Min deposit requirement. Free Bets are paid as Bet Credits and are available for use upon settlement of qualifying bets. Min odds, bet and payment method exclusions apply. Returns exclude Bet Credits stake. Time limits and T&Cs apply. William Hill: Bet 10 Get 30 Another beast in the industry is William Hill. This sports betting site is best known for its extensive and generous promotional page. Which includes its current bet 10 get 30 offer for the Royal Ascot. 18+. Play Safe. From 00:01 on 18.10.2022. £30 bonus. New customers only. Minimum £10 stake on odds of 1/2 (1.5) or greater on sportsbook (excluding Virtual markets). Further terms apply. Betfred: Bet 10 Get 40 This site is known for having detailed and helpful FAQs and customer support service, which helps players with everything they could need. Some guides you may find include how to claim their current bet 10 get 40 offer, how to bet on the Royal Ascot and a guide to betting odds. New 18+ UK customers only. Register using the promo code WELCOME40, deposit and place first bet of £10+ on Sports (cumulative Evens+) within 7 days of registration. First bet must be on Sports. £30 in Free Bets and £10 in Free Spins (50x20p) credited within 10 hours of bet settlement. Free Bet stakes are not included in any returns. Bonuses have a 7-day expiry. Payment restrictions apply. SMS verification and/or Proof of I.D and address may be required. Full T&Cs apply. BetVictor: Bet 10 Get 40 Not only does BetVictor offer a range of payment options and sport betting markets but also offers great promotions. For example, its current bet 10 get 40 offer rewards players for placing a first bet with them; the free bets cash bonus can then be used to be around the site, including on betting options for the Royal Ascot. 18+ New customers only. Opt in, bet £10+ at odds 2.00+, in 7 days. No cash out. Get 4x £10 Free Bets on selected events. 7 day bonuses expiry. Card payments only. T&Cs Apply, see below. begambleaware.org | Please gamble responsibly Betway: Matched Free Bet if your First Acca Loses Betway offers the most unique Royal Ascot promotion of all the sites on our list. What this offer means is that if you are to place an acca (accumulator) bet and it loses, you will receive a 30 free bets bonus to use on the Royal Ascot. *New UK customers only. Min Deposit: £5. Maximum Free Bet: £30. First bet on a Football or Horse Racing multiple with 3+ selections. Overall odds: 3.00 (2/1) or higher. Free Bets available upon settlement of the qualifying bet. This is offer is valid for 7 days from your new account being registered. 50 Bonus Spins credited on placement of qualifying Acca bet.50x bonus wagering applies as do weighting requirements, bonus Spins only available on selected games and expires 7 days after being awarded. Debit card deposits only (exclusions apply). 18+. BeGambleAware.org. Bet The Responsible Way. Full terms apply. 18+ Gambling Can Be Addictive. Please Play Responsibly. BeGambleAware GamStop Gambling Commission The Royal Ascot Day 4 Races Like the previous days, there will be seven races in total on day four; we have listed the name, time, distance and age group of each of these races below. Royal Ascot Day 4 Tips Starting off the fourth day is Albany Stakes, Group 3; this is a six-furlong group with fillies ages two only; this is another day on which a fast race kicks off the events of the day. Following this is the Commonwealth Cup, which is the most popular of the day. This race was established back in 2015 and is exclusively for fillies and colts aged three. Like the previous race, it is also six furlongs. Up next is the Duke of Edinburgh Handicap, a handicap race when each horse is allocated a weight baes on its ability to try and equalise every horse's chance of winning. The higher the horse's handicap, the more weight they are required to carry. The halfway point of the day, race four, is the Coronation Stakes which is across one mile and can only be run by fillies aged three. After this race is the Sandringham Stakes race which has the same conditions as the previous Britannia Stakes race on day three but is only open to three-year-old fillies, it is often shocking how much effect the conditions of a race have on a horse’s chance of winning, and this can include heat, rain or cold. For example, Hayley Tuner won at 33/1 odds two years running due to conditions and the effects it had on other horses. Race six is the King Edward VII Stakes which is a race run just over one mile (one mile and four furlongs). It is only open to Colts and Gelding, which are three years old. Last, in the day, race seven, is the Palace of Holyroodhouse Stakes, which is another handicap race. This race is only five furlongs, making it the quickest of the day. This is the largest race of the day, with sixty runners, all aged three. Conclusion In conclusion, bettors and racegoers should expect a similar fun and thrilling experience as they will have had on the previous three days. This is the day with the races with the most runners; one race even has a whopping sixty runners, which is the second largest race of the five days; the first is the Wokingham Stakes race on day five which has 66 runners. Frequently Asked Questions (FAQs) What is the best day at the Royal Ascot 2023? The best day for you will depend on what races you like to watch, however, many racegoers and bettors enjoy the Gold Cup race, which this year will take place on Thursday, the 22nd of June (day 3). Which royals will be at the Royal Ascot 2023? King Charles III and his wife, Queen Camilla, will be present for all five days of the event. Other royals that can be expected are Princess Anne, the Duke of Edinburgh, the Duke and Duchess of Cambridge and Cornwall and many more. What days are Royal Ascot 2023? The Royal Ascot 2023 will take place on Tuesday the 20th of June, and will last five days, to Saturday the 24th of June. Can I bet on the Royal Ascot Online? Yes, many online sportsbooks will offer Royal Ascot betting odds, and others will offer promotions all well, such as; Bet365, William Hill, Betfred, BetVictor and Betway. What dates are the Royal Ascot next year? Although the dates for next year’s Royal Ascot are not yet confirmed, we can tell you that it will likely take place around mid-June. Contact Details Acroud Media info-media@acroudmedia.com

June 23, 2023 05:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Bucket List Travel Not to Be Missed. The Wonders of New Zealand: The Trip Everyone Should Experience

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/DtFT0FSO4vc What’s on your bucket list? What adventure would you like to have or what place would you like to visit? With so many places worth traveling to, it can be hard to narrow down your top spots to visit. If your list has a location with epic national parks and stunning landscapes, inspiring culture, along with bustling nightlife and friendly locals, you might be thinking about New Zealand. The wonders of New Zealand are everywhere - the wonders of walking along the beach, hearing the waves crash, and exploring city life. The wonders are in the food that’s served, sights to be seen and the kind culture that is all around. The wonder is within the breathtaking landscape and environment the Island Nation is encapsulated within. New Zealand has no shortage of new wonders to taste! When dining in New Zealand, travelers are introduced to new senses and smells, and the experience of it all is as good as the meal. The New Zealand experience begins when you step onboard with Air New Zealand. With warm Kiwi hospitality and calming amenities, it’s a wonder to discover all its own. In fact, Air New Zealand recently refreshed their cabins to ensure restful sleep is at the heart of the travel experience. From the lighting to the seats themselves - Air New Zealand innovated from tip to tail. The Air New Zealand experience is nothing short of amazing - with friendly faces, a calming atmosphere and plenty of wine and food to choose from. On Air New Zealand, you can sleep better than you ever dreamed was possible! With more choices, like the Economy Skycouch - your personal couch in the sky! - you can stretch out and catch some Z’s allowing you to recharge before arriving in New Zealand. Visit AirNewZealand.com to book your bucket list getaway to New Zealand! Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 22, 2023 10:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Backyard Projects on a Budget

YourUpdateTV

With summer officially here, homeowners around the country are looking to refresh their backyard spaces and get ready for the all of the barbecues and family parties to come. Recently, Home Expert at Angi, Mallory Micetich, participated in a nationwide satellite media tour to discuss the top projects homeowners are undertaking this summer, tips on sticking to a budget, and how to know when it’s time to call in a pro. A video accompanying this announcement is available at: https://youtu.be/RLL1KozBUO8 According to a recent Angi survey - homeowners are planning a lot of projects this year. Top projects include building raised beds, laying new sod and adding a garden feature. Many of these projects can be DIY/ weekend warrior projects - especially if you have a green thumb - be mindful of what materials you are choosing for the project and take time to assess if these are actually good DIY projects for you. If you lack the time, tools or talent to take on a project, it might end up costing you more in the long run to fix any mistakes. One great way to take on a backyard project and keep to a budget is to pick a project with high visual impact and a lot of material choices - like adding a deck or a patio. With a range of decking and patio options there is one for every budget. Don’t forget to think about ongoing maintenance for your new backyard escape - dedicating some time and budget to ongoing maintenance will help keep your new yard in shape for years to come. Want to know how to keep on budget? Start by coming up with a realistic budget. Talk to several pros in your area to make sure you get high-quality work at a price that you’re comfortable with. Once you choose your pro, be very clear about your budget. A good pro will help you choose materials that work within your budget. You should also set aside 10% of the project cost for any unexpected expenses that come up during the renovation process. For more information, visit Angi.com About Mallory Micetich Mallory Micetich is a Home Care Expert, with particular expertise in small home living and consumer protection. While currently renting in Denver, CO, she has been a homeowner, investor, landlord and renter over the last decade. She is committed to minimizing her environmental footprint and to small home living, having lived in only properties of 1,000 square feet or less. Mallory is currently the VP of Corporate Communications at Angi, where she focuses on bringing awareness to Angi and what we do every day to help homeowners love where they live. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 22, 2023 09:37 AM Eastern Daylight Time

Video
Article thumbnail News Release

FTN Network Launches “The FTN Fantasy Show” on SiriusXM

FTN Network

The FTN Network, a data company exclusively built for delivering affordable, customizable, and highly detailed and accurate data for betting, season-long fantasy and daily fantasy, announced today the debut of its new SiriusXM Fantasy Sports Radio show, “The FTN Fantasy Show.” The show will be hosted by fantasy experts Jake Ciely, Chris Meaney and Lauren Carpenter, and will run from 9 - 11 a.m. ET every Saturday, beginning July 8, 2023 on SiriusXM channel 87. During each episode, hosts Ciely, senior writer for The Athletic, Meaney, Head of Media for FTN Network, and Carpenter, FTN Fantasy Analyst, will discuss fantasy football the way it should be: fun, insightful and daringly candid. The trio won't just deal takes; they will share their knowledge to help the viewer advance as a fantasy manager. Whether they need to "make a list" or debate milk before cereal, you will be laughing, as well as improving as a manager, with every show. “At FTN, we strive to be people’s go-to source for trusted, accurate and dependable fantasy football information and statistics,” said Kevin Adams, CEO and Founder of FTN Network. “Getting our own show on a platform like SiriusXM is an incredible opportunity to create a value-add for our diehard user base and introduce our brand and product to a massive new, and highly engaged, fantasy sports audience.” In May 2023, FTN announced its significant growth in Q1, stemming from a 54% increase in web traffic (year-over-year) across the FTN network of sites. Its 2023 subscription revenue was up 34% (year-over-year) across the FTN network of sites. For more information on FTN’s products and services, please visit its network of sites: FTNFantasy.com, FTNDaily.com and FTNBets.com. About FTN Network FTN Network is a sports data B2B and fantasy sports and betting media B2C company. Founded in 2020, FTN gives the fantasy and sports betting community an edge through their own unique ecosystem - providing customizable tools that turn raw data into true insights while also offering expert analysis and content to help users make the best decision possible. FTN Network consists of FTN Fantasy (the home of fantasy football), FTN Daily (the home of daily fantasy sports), FTN Bets (the home of sports betting insights) and FTN Data (the home of NFL data). Contact Details Sterling A. Randle +1 801-319-6153 srandle@hotpaperlantern.com

June 22, 2023 09:02 AM Eastern Daylight Time

Article thumbnail News Release

Accesso Technology Group to get "very big jumpstart" from VGS acquisition

Accesso Technology Group PLC

Accesso Technology Group PLC (AIM:ACSO, OTC:LOQPF) CEO Steve Brown speaks to Proactive after announcing the acquisition of VGS, a ticketing and visitor management platform and one of its main rivals in the theme park and attraction software business. Brown highlights the growth opportunity presented by VGS' established presence in the Middle East and Asia, saying that the purchase gives Accesso a "very big jumpstart" in those key growth markets. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

June 22, 2023 04:08 AM Eastern Daylight Time

Video
Article thumbnail News Release

Royal Ascot Day 3 Free Bets and Betting Offers

Acroud Media

Day three of the Royal Ascot 2023 is finally here and is one of the more glorious days. Officially halfway through this year's Royal Ascot, it is ladies' day down at the Ascot Racecourse in Newbury, filling the grounds with beautiful colours and fabulous attire. Additionally, bettors are anticipating the group 1 Gold Cup, one of the oldest races in Ascot history! To place bets on day 3 of the Royal Ascot 2023, bettors should visit the best sportsbooks offering horse racing coverage. Bet365 is offering its users a fantastic bet 10 get 30 welcome bonus for new customers. Keep reading to learn more about the schedule of day three and the betting tips for the day's races. List of the Best Betting Sites bet365 - bet 10 get 30 Min deposit requirement. Free Bets are paid as Bet Credits and are available for use upon settlement of qualifying bets. Min odds, bet and payment method exclusions apply. Returns exclude Bet Credits stake. Time limits and T&Cs apply. William Hill - bet 10 get 30 18+. Play Safe. From 00:01 on 18.10.2022. £30 bonus. New customers only. Minimum £10 stake on odds of 1/2 (1.5) or greater on sportsbook (excluding Virtual markets). Further terms apply. Betfred - bet 10 get 40 New 18+ UK customers only. Register using the promo code WELCOME40, deposit and place first bet of £10+ on Sports (cumulative Evens+) within 7 days of registration. First bet must be on Sports. £30 in Free Bets and £10 in Free Spins (50x20p) credited within 10 hours of bet settlement. Free Bet stakes are not included in any returns. Bonuses have a 7-day expiry. Payment restrictions apply. SMS verification and/or Proof of I.D and address may be required. Full T&Cs apply. BetVictor - bet 10 get 40 18+ New customers only. Opt in, bet £10+ at odds 2.00+, in 7 days. No cash out. Get 4x £10 Free Bets on selected events. 7 day bonuses expiry. Card payments only. T&Cs Apply, see below. begambleaware.org | Please gamble responsibly Betway - bet 10 get 30 *New UK customers only. Min Deposit: £5. Maximum Free Bet: £30. First bet on a Football or Horse Racing multiple with 3+ selections. Overall odds: 3.00 (2/1) or higher. Free Bets available upon settlement of the qualifying bet. This is offer is valid for 7 days from your new account being registered. 50 Bonus Spins credited on placement of qualifying Acca bet.50x bonus wagering applies as do weighting requirements, bonus Spins only available on selected games and expires 7 days after being awarded. Debit card deposits only (exclusions apply). 18+. BeGambleAware.org. Bet The Responsible Way. Full terms apply. 18+ Gambling Can Be Addictive. Please Play Responsibly. BeGambleAware GamStop Gambling Commission Royal Ascot Day Three The Royal Ascot 2023 event is officially well underway, and bettors are trying their luck placing bets on the seven infamous races Thursday the 22nd of June brings. The most anticipated race of the day is the Gold Cup, the oldest race to survive in the Royal Ascot competition, and its 500,000 prize pot certainly shows for this. To place your bets on these iconic races, visit William Hill, which is currently providing a Bet 10 get 30 offer to new customers to celebrate the races. More detail on day three’s schedule is listed below: Royal Ascot Day Three Tips Whether enjoying the competition from the Ascot Racecourse grounds or streaming the action from a sportsbook, all bettors will be excited for ladies' day at the Royal Ascot 2023. Our experts have accumulated the best tips for day 3 of the five-day event for bettors to take advantage of. To place your Royal Ascot 2023 bets, visit Betfred, that currently has a generous welcome offer where new users can bet 10 and get 40. To find out more about our expert selections, keep reading. The biggest race of the day, the Gold Cup, is a group 1 race that is the longest-standing in Royal Ascot history. With a fantastic prize pot of 500,000, only the best horses compete. Princess Zoe is the tip for this race due to previous performances, including beating Stradivarius. The first race of day three is the group two race, the Norfolk Stakes. The tip for this speedy race is Karl Burke’s Elit Status which is a hot favourite for this race. The exciting Ribblesdale Stakes, which is a group 2 race set to take place at 15:40, has Al Asifah as the tip. After success at Goodwood, this horse is certainly a favourite. The biggest threats to this tip include the brilliant Infinite Cosmos and Bluestocking. Using our expert tips, bettors can try their luck through the BetVictor sports book. The site is provided new users with a generous bet 10 and get 40 welcome bonus. Conclusion As the middle day of the Royal Ascot 2023, day three is undoubtedly feeling more relaxed however, the buzz is still there for eager bettors hoping to win some fabulous prizes. Day 3 of the Royal Ascot 2023 is ladies' day, where we can expect to see some fabulous displays of colour. Additionally, the Gold Cup is the most anticipated race of the day because it is the longest-standing event in Royal Ascot history. Bettors wanting to try their luck and potentially earn some brilliant free bets should visit the best sportsbooks offering coverage on this exciting event. FAQs When is the Royal Ascot 2023 taking place? This year's Royal Ascot takes place from the 20th-24th of June at the Ascot Racecourse in Berkshire. Are spectators allowed at the Royal Ascot 2023? Yes, racegoers can attend all five days of the Royal Ascot 2023. This is in accordance with government guidelines. How many races are on day 3 of the Royal Ascot 2023? There are a total of seven races on day 3 of the Royal Ascot 2023, with the infamous Gold Cup taking place at 16:15. Where do I place my bets on the Royal Ascot 2023? There is a selection of top sportsbooks for bettors to choose from during the Royal Ascot 2023, including Betway, which currently offers a new customer offer which entails a 30 matched free bet if their first acca loses. Contact Details Acroud Media info-media@acroudmedia.com

June 22, 2023 04:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Carey Bringle Partners with Josh Williams For Another Year at the NASCAR Xfinity Series

Peg Leg Porker

A few years after Carey Bringle opened the Peg Leg Porker restaurant, he got a call from an ARCA race car driver's manager asking if he would feed a team in exchange for a sticker on his car in the Nashville race. She talked about how this independent driver visited children's hospitals in every city he raced in. The story hit home for Carey, a pediatric cancer survivor himself. That driver was Josh Williams and he won the race that night. Ever since that race, Josh and Carey have kept in touch and Peg Leg Porker has sponsored Josh's car in his Nashville races. Since that time, Carey started more ventures and Josh moved up to the Xfinity series. One thing didn't change, the connection between the two. Both are fiercely independent and both share a passion for supporting charitable causes. In fact, last year, Josh was a finalist for the Comcast Community Champion Award. The ceremony was in Nashville and Carey was right there to support Josh's amazing charitable work across the country. This year is no different. Peg Leg Porker will again be a sponsor on Josh's car and while Josh is in town, he will make a visit to Vanderbilt Children's Hospital. The TN Lottery 250 is this weekend on Saturday at the Nashville Superspeedway. The race starts with driver intros at 2:00 CST. A Nashville native, pitmaster Carey Bringle has been competing in barbecue contests for more than 27 years, and has the blue ribbons to prove it. With a deep southern background built around family values and appreciating a good meal, Bringle founded Peg Leg Porker in 2013. Peg Leg Porker is named after Bringle himself and his greatest win, a cancer battle that he triumphed at the age of 17. With his win, he lost his leg, which led him to create a new name and only added more fire to his passion for success. What started out as a whole hog BBQ team and catering business, turned into a whole lifestyle brand, inclusive of spirits, sauces and spices, to accompany world-class BBQ. Upon opening its doors in the heart of Nashville, Peg Leg Porker was quickly named one of the hottest BBQ joints in the country by numerous media outlets, including Food Network, The Travel Channel, BBC, Southern Living Magazine, Texas Monthly, GQ, Garden and Gun Magazine, and many more. Peg Leg Porker is known for its juicy, smoked-to-perfection pork ribs drenched with a spicy dry seasoning *after* being smoked. Not to mention they're made from scratch, yet playful sides, like Kool-Aid pickles and pork rind nachos, plus Peg Leg Porker’s southern hospitality have guests feeling right at home. Peg Leg Porker has expanded, sharing their ‘cue with fans all over the world with their e-commerce site to ship nationwide. Although many wish Bringle would open another location, there will only be one Peg Leg Porker. Bringle says, “We’re building a legacy, not a chain.” This year, they will be celebrating a decade of being a part of the Nashville community and are excited to continue to be a part of it for many years to come. Contact Details Madison Baber +1 210-213-2426 madison@rprfirm.com Company Website https://www.peglegporker.com/

June 21, 2023 04:00 PM Central Daylight Time

1 ... 123124125126127 ... 374